aTYR PHARMA INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
aTYR PHARMA INC (ATYR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 296.52 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-08-07
- aTYR PHARMA INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-06-30 was 156.91K shares, a 951.34% increase year-over-year.
- aTYR PHARMA INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2026-03-31 was 139.61K shares, a 401.37% increase year-over-year.
- aTYR PHARMA INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-12-31 was 356.06K shares, a 11242.98% increase year-over-year.
- aTYR PHARMA INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2025-09-30 was 2.45K shares, a 38.68% decline year-over-year.
- aTYR PHARMA INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2025 was 401.28K shares, a 623.04% increase from fiscal 2024.
- aTYR PHARMA INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2024 was 55.50K shares, a 50.55% decline from fiscal 2023.
- aTYR PHARMA INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2023 was 112.23K shares, a 138.96% increase from fiscal 2022.
- aTYR PHARMA INC share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2022 was 46.97K shares, a 3.28% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 156.91K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | 296.52K shares 10-Q · filed 2026-08-07 | 652.58K shares derived: sum of 3 quarters · filed 2026-08-07 | 655.03K shares derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | 139.61K shares 10-Q · filed 2026-05-15 | 495.66K shares derived: sum of 2 quarters · filed 2026-05-15 | 498.12K shares derived: sum of 3 quarters · filed 2026-05-15 | 513.04K shares derived: sum of 4 quarters · filed 2026-05-15 |
| 2025-12-31 | 356.06K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | 358.51K shares derived: sum of 2 quarters · filed 2026-03-05 | 373.43K shares derived: sum of 3 quarters · filed 2026-03-05 | 401.28K shares 10-K · filed 2026-03-05 |
| 2025-09-30 | 2.45K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 17.38K shares derived: sum of 2 quarters · filed 2025-11-06 | 45.22K shares 10-Q · filed 2025-11-06 | 48.36K shares derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | 14.93K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 42.77K shares 10-Q · filed 2025-08-07 | 45.91K shares derived: sum of 3 quarters · filed 2025-08-07 | 49.91K shares derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | 27.84K shares 10-Q · filed 2025-05-07 | 30.98K shares derived: sum of 2 quarters · filed 2025-05-07 | 34.98K shares derived: sum of 3 quarters · filed 2025-05-07 | 47.93K shares derived: sum of 4 quarters · filed 2025-05-07 |
| 2024-12-31 | 3.14K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | 7.14K shares derived: sum of 2 quarters · filed 2025-03-13 | 20.08K shares derived: sum of 3 quarters · filed 2025-03-13 | 55.50K shares 10-K · filed 2025-03-13 |
| 2024-09-30 | 4.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 16.94K shares derived: sum of 2 quarters · filed 2024-11-07 | 52.36K shares 10-Q · filed 2024-11-07 | 67.84K shares derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | 12.94K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 48.36K shares 10-Q · filed 2024-08-13 | 63.84K shares derived: sum of 3 quarters · filed 2024-08-13 | 64.30K shares derived: sum of 4 quarters · filed 2024-08-13 |
| 2024-03-31 | 35.42K shares 10-Q · filed 2024-05-02 | 50.90K shares derived: sum of 2 quarters · filed 2024-05-02 | 51.35K shares derived: sum of 3 quarters · filed 2024-05-02 | 76.59K shares derived: sum of 4 quarters · filed 2024-05-02 |
| 2023-12-31 | 15.48K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | 15.94K shares derived: sum of 2 quarters · filed 2024-03-14 | 41.18K shares derived: sum of 3 quarters · filed 2024-03-14 | 112.23K shares 10-K · filed 2024-03-14 |
| 2023-09-30 | 458.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 25.70K shares derived: sum of 2 quarters · filed 2023-11-09 | 96.75K shares 10-Q · filed 2023-11-09 | 118.21K shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | 25.24K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | 96.29K shares 10-Q · filed 2023-08-09 | 117.75K shares derived: sum of 3 quarters · filed 2023-08-09 | 129.72K shares derived: sum of 4 quarters · filed 2023-08-09 |
| 2023-03-31 | 71.05K shares 10-Q · filed 2023-05-09 | 92.51K shares derived: sum of 2 quarters · filed 2023-05-09 | 104.48K shares derived: sum of 3 quarters · filed 2023-05-09 | 112.54K shares derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | 21.46K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | 33.43K shares derived: sum of 2 quarters · filed 2023-03-14 | 41.49K shares derived: sum of 3 quarters · filed 2023-03-14 | 46.97K shares 10-K · filed 2023-03-14 |
| 2022-09-30 | 11.97K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 20.03K shares derived: sum of 2 quarters · filed 2022-11-14 | 25.50K shares 10-Q · filed 2022-11-14 | 26.61K shares derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | 8.06K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | 13.54K shares 10-Q · filed 2022-08-15 | 14.64K shares derived: sum of 3 quarters · filed 2022-08-15 | 25.24K shares derived: sum of 4 quarters · filed 2022-08-15 |
| 2022-03-31 | 5.48K shares 10-Q · filed 2022-05-10 | 6.58K shares derived: sum of 2 quarters · filed 2022-05-10 | 17.18K shares derived: sum of 3 quarters · filed 2022-05-10 | 38.77K shares derived: sum of 4 quarters · filed 2022-05-10 |
| 2021-12-31 | 1.11K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | 11.70K shares derived: sum of 2 quarters · filed 2022-03-15 | 33.29K shares derived: sum of 3 quarters · filed 2022-03-15 | 45.47K shares 10-K · filed 2022-03-15 |
| 2021-09-30 | 10.59K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | 32.18K shares derived: sum of 2 quarters · filed 2021-11-12 | 44.36K shares 10-Q · filed 2021-11-12 | 45.13K shares derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-06-30 | 21.59K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | 33.77K shares 10-Q · filed 2021-08-11 | 34.54K shares derived: sum of 3 quarters · filed 2021-08-11 | 146.83K shares derived: sum of 4 quarters · filed 2021-08-11 |
| 2021-03-31 | 12.18K shares 10-Q · filed 2021-05-14 | 12.96K shares derived: sum of 2 quarters · filed 2021-05-14 | 125.24K shares derived: sum of 3 quarters · filed 2021-05-14 | 160.23K shares derived: sum of 4 quarters · filed 2021-05-14 |
| 2020-12-31 | 771.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | 113.06K shares derived: sum of 2 quarters · filed 2021-03-24 | 148.04K shares derived: sum of 3 quarters · filed 2021-03-24 | 186.98K shares 10-K · filed 2021-03-24 |
| 2020-09-30 | 112.29K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | 147.27K shares derived: sum of 2 quarters · filed 2020-11-13 | 186.21K shares 10-Q · filed 2020-11-13 | 225.08K shares derived: sum of 4 quarters · filed 2020-11-13 |
| 2020-06-30 | 34.98K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | 73.92K shares 10-Q · filed 2020-08-13 | 112.80K shares derived: sum of 3 quarters · filed 2020-08-13 | 120.44K shares derived: sum of 4 quarters · filed 2020-08-13 |
| 2020-03-31 | 38.93K shares 10-Q · filed 2020-05-12 | 77.81K shares derived: sum of 2 quarters · filed 2020-05-12 | 85.46K shares derived: sum of 3 quarters · filed 2020-05-12 | -344.50K shares derived: sum of 4 quarters · filed 2020-05-12 |
| 2019-12-31 | 38.88K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | 46.53K shares derived: sum of 2 quarters · filed 2020-03-26 | -383.43K shares derived: sum of 3 quarters · filed 2020-03-26 | 82.00K shares 10-K · filed 2020-03-26 |
| 2019-09-30 | 7.65K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -422.31K shares derived: sum of 2 quarters · filed 2019-11-14 | 43.12K shares 10-Q · filed 2019-11-14 | 496.63K shares derived: sum of 4 quarters · filed 2019-11-14 |
| 2019-06-30 | -429.96K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | 35.47K shares 10-Q · filed 2019-08-14 | 488.99K shares derived: sum of 3 quarters · filed 2019-08-14 | 1.01M shares derived: sum of 4 quarters · filed 2019-08-14 |
| 2019-03-31 | 465.43K shares 10-Q · filed 2019-05-14 | 918.95K shares derived: sum of 2 quarters · filed 2019-05-14 | 1.44M shares derived: sum of 3 quarters · filed 2019-05-14 | 1.91M shares derived: sum of 4 quarters · filed 2019-05-14 |
| 2018-12-31 | 453.52K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | 976.78K shares derived: sum of 2 quarters · filed 2019-03-26 | 1.45M shares derived: sum of 3 quarters · filed 2019-03-26 | 1.71M shares 10-K · filed 2019-03-26 |
| 2018-09-30 | 523.26K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | 993.08K shares derived: sum of 2 quarters · filed 2018-11-14 | 1.25M shares 10-Q · filed 2018-11-14 | 1.75M shares derived: sum of 4 quarters · filed 2018-11-14 |
| 2018-06-30 | 469.81K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | 728.83K shares 10-Q · filed 2018-08-14 | 1.23M shares derived: sum of 3 quarters · filed 2018-08-14 | 1.30M shares derived: sum of 4 quarters · filed 2018-08-14 |
| 2018-03-31 | 259.01K shares 10-Q · filed 2018-05-15 | 761.80K shares derived: sum of 2 quarters · filed 2018-05-15 | 832.57K shares derived: sum of 3 quarters · filed 2018-05-15 | 966.88K shares derived: sum of 4 quarters · filed 2018-05-15 |
| 2017-12-31 | 502.79K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | 573.56K shares derived: sum of 2 quarters · filed 2018-03-20 | 707.87K shares derived: sum of 3 quarters · filed 2018-03-20 | 830.76K shares 10-K · filed 2018-03-20 |
| 2017-09-30 | 70.77K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | 205.08K shares derived: sum of 2 quarters · filed 2017-11-14 | 327.97K shares 10-Q · filed 2017-11-14 | 565.32K shares derived: sum of 4 quarters · filed 2017-11-14 |
| 2017-06-30 | 134.31K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | 257.20K shares 10-Q · filed 2017-08-14 | 494.55K shares derived: sum of 3 quarters · filed 2017-08-14 | |
| 2017-03-31 | 122.89K shares 10-Q · filed 2017-05-11 | 360.24K shares derived: sum of 2 quarters · filed 2017-05-11 | ||
| 2016-12-31 | 237.35K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | 860.82K shares 10-K · filed 2017-03-16 | ||
| 2016-09-30 | 623.47K shares 10-Q · filed 2016-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |